bioRxivBioengineering
Iterative transcription factor screening enables rapid generation of microglia-like cells from human iPSC
S. Liu, L. Li, F. Zhang, B. van Sambeek, E. Appleton, A. H. M. Ng, P. Khoshakhlagh, Y. Chen, M. Garcia-Corral, C.-T. Wu, J. Y. Huang, Y. Tan, G. Chao, J. Aach, J. Tam, E. T. Lim, S. Raychaudhuri, G. Church
Abstract
The ability to differentiate stem cells into human cell types is essential to define basic mechanisms and therapeutics, especially for cell types not routinely accessible by biopsies. But while engineered expression of transcription factors (TFs) identified through TF screens has been found to rapidly and efficiently produce some cell types, generation of other cell types that require complex combinations of TFs has been elusive. Here we develop an iterative, pooled single-cell TF screening method that improves the identification of effective TF combinations using the generation of human microglia-like cells as a testbed: Two iterations identified a combination of SPI1, CEBPA, FLI1, MEF2C, CEBPB, and IRF8 as sufficient to differentiate human iPSC into microglia-like cells in 4 days. Characterization of TF-induced microglia demonstrated molecular and functional similarity to primary microglia. We explore the use of single-cell atlas reference datasets to confirm identified TFs and how combining single-cell TF perturbation and gene expression data can enable the construction of causal gene regulatory networks. We describe what will be needed to fashion these methods into a generalized integrated pipeline, further ideas for enhancement, and possible applications.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: gene regulatory network inference
- approach: deep learning
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptomics defines an improved, validated monoculture protocol for differentiation of human iPSCs to microglia
S. J. Washer, M. Perez-Alcantara, … S. A. Cowley·bioRxiv·Aug 2, 2022
- A xeno-free protocol for rapid differentiation of human iPSC-derived microglia from the KOLF2.1J reference line.
Nélio Alessandro de Jesus Oliveira, Katherine R. Lewkowicz, … Justin A. McDonough·BioengineeringPeer-reviewed·Dec 30, 2025
- KOLF2.1J iTF-Microglia: A standardized platform to studymicroglial transcriptional regulatory networks in CNS disease
Iván Rodríguez-Nunez, Samuel C. Bartley, … R Myers·bioRxiv·May 30, 2025
- Transcriptional characterization of iPSC-derived microglia as a model for therapeutic development in neurodegeneration
Gokul Ramaswami, Yeliz Yuva-Aydemir, … David A. Bumcrot·Scientific ReportsPeer-reviewed·Jan 25, 2024
- A CRISPRi/a platform in iPSC-derived microglia uncovers regulators of disease states
Nina M. Dräger, Sydney M. Sattler, … Martin Kampmann·bioRxiv·Jun 16, 2021
- Comparing the potential of microglia preparations generated using different human iPSC-based differentiation methods to model microglia-mediated mechanisms of amyotrophic lateral sclerosis pathophysiology
Ye Man Tang, Nisha S. Pulimood, Stefano Stifani·ASN NEUROPeer-reviewed·Jan 1, 2022